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Early growth response factor-1 (EGR-1) is an immediate early
gene, which is rapidly activated in quiescent cells by mitogens
or in postmitotic neurons after depolarization. EGR-1 has been
involved in diverse biological functions such as cell growth, dif-
ferentiation and apoptosis. Here we report that enforced expres-
sion of the EGR-1 gene induces apoptosis, as determined by flow
cytometry and terminal deoxynucleotidyl transferase-mediated
dUTP-fluorescein nick-end labelling (TUNEL) analysis, in mu-
rine Neuro2A cells. In accordance with this role of EGR-1 in
cell death, antisense oligonucleotides increase cell viability
in cells cultured in the absence of serum. This apoptotic activity
of the EGR-1 appears to be mediated by p73, a member of the
p53 family of proteins, since an increase in the amount of p73
is observed in clones stably expressing the EGR-1 protein. We also
observed an increase in the transcriptional activity of the mdm2
promoter in cells overexpressing EGR-1, which is paralleled by a
marked decrease in the levels of p53 protein, therefore excluding
a role of this protein in mediating EGR-1-induced apoptosis. Our
results suggest that EGR-1 is an important factor involved in
neuronal apoptosis.
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INTRODUCTION
Regulation of cell death is essential for normal development
and is an important defence against viral infection, cancer and
degenerative diseases [1]. Cells of the central nervous system
leave the mitotic cycle and differentiate early in development
[2]. Later, in maturation, a massive-scale death of neurons and
oligodendrocytes occurs as part of the normal physiological
process of development [3,4]. The affected cells are thought to be
neurons that have failed to form connections with a target and thus
lack target-derived support, such as specific neurotrophic factors
[4], and oligodendrocytes that have failed to obtain the growth
factors, cytokines and neurotrophic factors necessary for their
survival [5,6]. This neuronal cell death has been shown to occur
via apoptosis [7]. Neuronal cell death can occur abnormally by
its timing, its causes or its extent. This is obviously of particular
importance when the human nervous system is concerned, where
extensive neuronal cell death is observed in neurodegenerative
diseases and after stroke and trauma [8–10].
The protein products of numerous genes exert activating or
inhibitory effects on apoptosis. Therefore the identification and
characterization of the function of these genes will help to define
the process of cell death at the biochemical level and suggest sites
of therapeutical intervention. The initial nuclear events that trigger
the apoptotic programme in developing neurons are still unknown
although a number of immediate early genes, including members
of the fos and jun families, have been implicated. Previous studies
observed a significant induction in the level of c-jun and c-fos in
cultured sympathetic neurons that were destined to die [11,12],
and an augmented expression of early growth response factor-1
(EGR-1) has been recently associated with cerebellar granule cell
death in culture [13].
Abbreviations used: EGR-1, early growth response factor-1; TdT, terminal deoxynucleotidyl transferase; TUNEL, TdT-mediated dUTP-fluorescein
nick-end labelling; DMEM, Dulbecco’s modified Eagle’s medium; FBS, fetal bovine serum; PI, propidium iodide.
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EGR-1 (also known as NGFI-A, krox24, zif 268 and tis 8) is
an immediate early gene that was identified simultaneously in
different cell systems [14,15]. EGR-1 is a nuclear DNA-binding
protein which specifically recognizes the sequence: 5′-GCGKG-
GGCG-3′ and can transactivate promoters containing the appro-
priate cognate site [16]. Promoters containing active binding/
transcription sites for EGR-1 include those of the thymidine
kinase, tumour necrosis factor, both chains of platelet-derived
growth factor, synapsins [17,18], acetylcholinesterase and N-
methyl-D-aspartate receptor 1 (NMDAR-1) [19,20]. Several stu-
dies have suggested a role for the EGR-1 protein in the regulation
of cell division, differentiation and apoptosis. It has been shown
that expression of EGR-1 is induced during differentiation of
myeloid cells [21,22], and more recently we have demonstrated an
involvement of this protein in the differentiation of neuronal cells
[23]. Accumulated evidence suggests that the EGR-1 gene may
play an important role in the nervous system. First it is expressed
widely in the peripheral and central nervous systems in adult and
developing animals [24,25]. Second, EGR-1 gene expression is
highly responsive to neuronal stimulation and the levels of EGR-1
mRNA in the brain increases dramatically in animals that have had
a seizure [26]. We have also reported an up-regulation of EGR-1
gene expression by thyroid hormone [25,27], receptors for which
are likely to play a role in events such as neuronal differenti-
ation, establishment of interneuronal connections and cell death
[28,29].
In this study we have used the Neuro2A cells (N2A cells)
to investigate the role of the transcription factor EGR-1 on
programmed cell death. Our results show a significant increase
in apoptosis in N2A cells stably transfected with an expression
vector for EGR-1, as well as a reduction in cells treated with
EGR-1 antisense oligonucleotides. Furthermore, EGR-1-induced
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apoptosis appears to be independent of the cell-cycle checkpoint
gene p53, but dependent on the p73 protein, since a simultaneous
decrease in p53 and increase in p73 protein was observed in cells
overexpressing EGR-1.
MATERIALS AND METHODS
Cell culture and transfection
Mouse N2A and clones NG9 and NG10 [23], overexpressing
the EGR-1 protein, were grown in Dulbecco’s modified Eagle’s
medium (DMEM) plus 10% fetal bovine serum (FBS; Gibco
Laboratories, Grand Island, NY, U.S.A.), 2 mM glutamine and
0.01 mg/ml sodium pyruvate. For all experiments, cells were
seeded at a density of 20 000/cm2 and grown for 24 h in complete
medium before any treatment was started. In the absence of serum,
N2A cells first differentiate (12–24 h) and later they start to die
(24–32 h) [23]. Antisense or sense oligonucleotides were added
to the culture medium at a concentration of 40 µM at the same
time of serum withdrawal. For transient transfection experiments
(EGR-1, mdm2 and pG13), semiconfluent cells were transfected
by the calcium phosphate precipitation technique in 24-well
plates. After 8 h of exposure to the Ca2+–DNA mixture, cells
were washed with TD buffer (20 mM Tris/HCl, pH 7.4, 1 mM
Na2HPO4, 140 mM NaCl and 5 mM KCl), incubated for another
24 h in complete medium, and harvested for determination of
luciferase activity as described previously [30]. Each transient
transfection experiment was repeated at least three times in
triplicate. For the study of EGR-1 transcriptional activity, we
used a construct containing two EGR-1 consensus-binding sites
upstream of a prolactin minimal promoter [31].
The pSUPER vector directing the synthesis of a 19-bp double-
stranded p53 target sequence (pSUPER/p53) was used to suppress
the endogenous p53 gene [32]. N2A parental cells and clones NG9
and NG10 were transfected either with the anti-p53 construct
or with the empty vector (pSUPER) by the calcium phosphate
precipitation technique, as indicated above. With this method
we obtained more than 90% transfection efficiency. After trans-
fection (50 h) the amount of p53 protein and the percentage of
apoptotic cells were determined.
Oligonucleotides
EGR-1 antisense and sense oligodeoxyribonucleotides with the
sequences (antisense) 5′-GCG GGG TGC AGG GGC ACA CT-3′
and (sense) 5′-AGT GTG CCC CTG CAC CCC GC-3′ were
synthesized with an Applied Biosystems 391 DNA synthesizer
and purified on acrylamide gels. The antisense oligonucleotide
is complementary to a sequence located 120–101 bp upstream
of the AUG initiation codon. A 15-mer antisense oligodeoxyribo-
nucleotide with the sequence 5′-GGG GTA GTT GTC CAT-
3′, complementary to a sequence starting at the AUG initiation
codon, was also used with the same results. The oligonucleotides
used to amplify a 400-bp fragment of the mouse P2 mdm2
internal promoter [33] were as follows: antisense, 5′-GGG CCC
GCT CCG GGT CGC GCT-3′, and sense, 5′-ATG CAT TTA
CGA AGG AGA-3′. The oligonucleotides used to construct the
pSUPER/p53 vector were as follows: forward primer, 5′-GAT
CCC CGA CTC CAG TGG GAA CCT TCT TCA AGA GAG
AAG GTT CCC ACT GGA GTC TTT TTG GAA A-3′, and
reverse primer, 5′-AGC TTT TCC AAA GAC TCC AGT GGT
AAT CTA TCT CTT GAA GAA GGT TCC CAC TGG AGT
CGG G-3′.
Western immunoblot analysis
N2A cells were lysed in 500 µl of PBS containing 1% Nonidet
P-40, 0.5% sodium deoxycholate, 0.1% SDS and protease in-
hibitors, centrifuged at 12 000 g for 20 min and the supernatants
removed and stored at − 70 ◦C until analysis. Equal amounts of
protein (70 µg) were electrophoresed in SDS/10%-acrylamide
gels, and blotted on to nitrocellulose membranes. Transferred
membranes were blocked with 5% non-fat milk in TBST buffer
(20 mM Tris/HCl, pH 7.6, 130 mM NaCl and 0.1% Tween 20)
for 1 h at room temperature and incubated with EGR-1-, p53-,
mdm2- or p73-specific antibodies (Santa Cruz Biotechnology)
used all at 1:1000 dilution, in TBST with 4% non-fat milk for
2 h. The anti-α-tubulin antibody was obtained from Sigma and
used at a 1:4000 dilution. After several washes with TBST, the
membranes were incubated with the corresponding horseradish
peroxidase-coupled secondary antibodies in the same buffer.
After washing, immunoreactive bands were visualized using
Amersham’s ECL detection kit according to the manufacturer’s
instructions.
Cell viability and apoptosis assays
To assess cell viability, aliquots of cells were mixed with Trypan
Blue (1:1) and loaded on to a haemocytometer, and the percent-
age of dead cells per sample was calculated. Survival assays were
carried out independently at least three times. To calculate the
percentage of dead cells, 1 × 106 cells were cultured in 10-cm-
diameter tissue-culture plates and grown in DMEM for 24 h
before switching to DMEM without FBS for a further 32 h. Apo-
ptosis was assayed using propidium iodide (PI) staining and
FACS analysis, and a minimum of 10 000 events were collected
for each sample. Data are presented using the dot density plot
function. Regions R3 plus R4 correspond to the apoptotic popula-
tion. Cells in panel R2 correspond to dead cells that have altered
the membrane permeability. The data were analysed using the
CellQuest software package (Becton Dickinson). For microscopy
analysis, cells were grown on coverslips for 32 h in normal or
serum-free medium, stained with 0.01% PI and examined with a
Zeiss Axiophot microscope.
Terminal deoxynucleotidyl transferase (TdT)-mediated
dUTP-fluorescein nick-end labelling (TUNEL) assay
Apoptosis was also measured by the TUNEL method. Genomic
DNA strand breaks characteristic of apoptosis were labelled
in situ by TdT using an in situ cell-death-detection kit (Kamiya
Biomedical Com., Seattle, WA, U.S.A.) according to the manu-
facturer’s instructions. Briefly, N2A cells were grown in chamber
slides (Becton Dickinson) for 24 h, changed to serum-free
media and maintained for 32 h. Cells were fixed with 5% para-
formaldehyde solution in PBS for 30 min at room temperature
and then permeabilized with 0.1% Triton X-100 in PBS for
10 min. The cells were then exposed to the TUNEL reaction
mixture containing the TdT enzyme and fluorescein-labelled nu-
cleotides, washed and photographed under a fluorescence Zeiss
Axiophot microscope.
Statistical analysis
The data were analysed using the StatWorks software package.
Significant effects were determined using Student’s t test. A
statistically significant difference was considered to be present
at P 0.05.
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Figure 1 Levels of EGR-1 protein and transcriptional activity
(A) Representative Western blot of EGR-1 protein in clones NG9 and NG10 grown in the absence
or presence of FBS. (B) N2A cells and clones NG9 and NG10 were transfected with 0.5 µg of
an EGR-1 reporter construct, and 24 h after transfection luciferase activity of cell lysates was
determined. Values represent the means +− S.D. from three different experiments; *P  0.05,
**P  0.01.
RESULTS
Effects of EGR-1 on N2A survival
First of all, we analysed the transcriptional activity of the EGR-1
protein in N2A parental cells and in the clones overexpressing
this protein (NG9 and NG10). For that purpose, we transfected
parental N2A cells and clones NG9 and NG10 with a vector
containing two EGR-1 consensus binding sites cloned in front
of the prolactin minimal promoter. As shown in Figure 1(B) the
transcriptional activity of this construct, in the presence as well
as in the absence of serum, is 3-fold higher in NG9 and NG10
clones, compared with the activity observed in parental N2A
cells. These data suggest that the transcriptional activity of EGR-1
is increased in cells overexpressing this protein. In addition, as
can be observed in Figure 1(A), the levels of EGR-1 protein do
not change significantly in cells growing in serum-free medium
compared with cells growing in regular conditions (medium plus
FBS).
To determine whether overexpression of EGR-1 directly
affected the survival of N2A cells, we tested control cells and
clones NG9 and NG10, overexpressing EGR-1, for their ability
to exclude a vital dye such as Trypan Blue. As shown in Figure 2,
EGR-1 overexpression caused a significant increase in the number
of Trypan Blue-positive cells. This increment was observed in
the presence as well as in the absence of serum, although the
differences in survival between controls and cells overexpressing
EGR-1 were higher in the cells growing in the presence of serum.
Our results show 3- and 2-fold (NG9 and NG10, respectively)
increases in the number of Trypan Blue-positive cells, compared
with parental N2A and vector-alone-expressing cells (pLNCX),
in cells growing in the presence of serum, whereas this increase
was only 1.5- and 1.4-fold (NG9 and NG10, respectively) in cells
cultured in serum-free medium.
To analyse the effect of EGR-1 on apoptosis, N2A control cells
and clones NG9 and NG10 were treated with 0.01%PI, visualized
Figure 2 Percentage of Trypan Blue-positive cells in different clones
overexpressing the EGR-1 protein
Cells were grown in DMEM plus 10 % FBS for 24 h and then some of the plates were switched
to medium without serum. Afterwards all the cells were incubated for a further 32 h. pLNCX
represents N2A cells stably transfected with an empty vector. Values represent the means +− S.D.
from three different experiments; *P  0.05, **P  0.01.
by fluorescence microscopy and quantified by flow cytometry.
Morphological examinations by fluorescence microscopy showed
that the amount of apoptotic nuclei, in cells growing in the
presence or absence of serum, was higher in transfectant compared
with control cells (Figure 3A). Quantification of apoptosis by
flow cytometry (Figures 3B and 3C) showed that, in the presence
of serum, up to 12.5 and 18.2% of the NG9 and NG10 cells,
respectively, displayed a typical pattern of apoptosis (R3 + R4),
compared with 6% in the control cells. In the absence of
serum, the EGR-1-expressing cells showed also a significant
enhancement of the apoptotic population (15.4 and 18.5% in
NG9 and NG10 respectively) in comparison with control cells
(10.5%). Cells expressing the vector alone gave the same results,
as did the wild-type N2A cells (not shown). The total percentages
of necrotic + apoptotic population (R2 + R3 + R4), measured
by flow cytometry, were essentially identical to those obtained by
Trypan Blue exclusion (Figure 2).
A typical molecular characteristic of apoptosis is genomic DNA
cleavage into internucleosomal segments attributed to the specific
activation of an endogenous endonuclease. This apoptosis-
specific genomic DNA cleavage was also assessed by the TUNEL
assay. Using this technique we demonstrated further that EGR-
1-induced cell death was due to an apoptosis-like mechanism.
N2A control and NG9 and NG10 clones were cultured in
the absence of serum and assayed for DNA strand breakage.
Control (N2A) cells showed very limited fluorescent labelling,
whereas NG9 and NG10 clones showed numerous positive cells
(Figure 4). These results indicate that death is due to an apoptotic
process.
Once we established that EGR-1 overexpression induces apop-
tosis in N2A cells, we next studied whether treatment with EGR-1
antisense oligodeoxyribonucleotide could result in a diminution
of the apoptotic population induced by serum deprivation.
For that purpose, parental N2A cells were grown in serum-
deprived media in the presence or absence of EGR-1 antisense
for 32 h and stained with PI. As shown in Figure 5 the addition of
EGR-1 antisense oligonucleotides to the culture medium produces
a dramatic decrease in the levels of EGR-1 protein (Figure 5A) and
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Figure 3 Apoptosis induction by the overexpression of the EGR-1 gene
(A) Two different clones were cultured for 32 h in normal or serum-free medium and apoptotic cells were detected by PI staining. Phase-contrast (right-hand images) and fluorescence (left-hand
images) photomicrographs were taken; magnification, × 100; scale bars, 30 µm. (B) Representative dot density plot of freshly prepared N2A clones, cultured in the same conditions as (A) and
examined by flow cytometry for PI staining. R1, live cells; R2, necrotic cells; R3 + R4, apoptotic cells. fsc, forward scatter. (C) Quantitative determination of apoptotic and necrotic cells deter-
mined by PI staining and flow cytometry. Values represent the means +− S.D. from at least three different experiments; *P  0.05, **P  0.01.
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Figure 4 Detection of N2A cells undergoing apoptosis using the TUNEL
technique
Cells were seeded and grown in medium containing 10 % FBS for 24 h. Then, some of the
cultures were induced to die by growing in the absence of serum for 32 h. Afterwards the TUNEL
assay was performed by labelling the apoptosis-specific DNA strand breaks with fluorescent
label as described in the Materials and methods section.
Figure 5 Effect of EGR-1 antisense oligonucleotides on PI staining of N2A
cells
Cells were seeded and grown for 24 h in medium containing 10 % FBS. Then the cultures were
grown for 32 and 48 h in normal or serum-deprived medium with or without 40 µM EGR-1
sense or antisense oligodeoxynucleotides. (A) Representative Western blot showing the effects of
antisense oligodeoxynucleotides on EGR-1 protein levels. (B) Fluorescent photomicrographs
of cultures stained with PI, as indicated in the Materials and methods section. S, sense, AS,
antisense. Magnification, × 50; scale bars, 40 µm.
the number of PI-positive cells (5B), suggesting an implication
of the endogenous EGR-1 gene in the apoptosis induced by serum
withdrawal.
Figure 6 Effect of EGR-1 on p53 expression
(A) The protein levels of p53 in parental N2A cells and clones NG9 and NG10 were determined
by Western-blot analysis. Equal protein amounts (20 µg) of each sample were subjected to
SDS/PAGE, transferred to nitrocellulose and blots incubated with specific anti-p53 as described
in the Materials and methods section. (B) Parental N2A cells were transiently transfected with
a luciferase reporter plasmid containing 400 bp of the P2 mdm2 promoter and 0.3 µg of an
EGR-1 expression vector. Data represent the means +− S.D. of luciferase activity determined in
triplicate in at least two independent experiments, and are expressed relative to the basal value
obtained with only the reporter construct. (C) Parental and EGR-1-overexpressing cells were
transiently transfected with the same luciferase reporter plasmid as in (B), and luciferase activity
was measured. Data represent the means +− S.D. of luciferase activity determined in triplicate in
at least two independent experiments, and are expressed relative to the value obtained with the
parental N2A cells; **P  0.01, ***P  0.001.
Regulation of p53 family proteins by EGR-1
Since p53 protein has been implicated in EGR-1-mediated
apoptosis in melanoma cells [34], we further tested the ability of
EGR-1 to regulate the endogenous p53 gene in N2A cells. There-
fore, we measured the levels of p53 protein in parental N2A
cells and clones NG9 and NG10. Surprisingly, these two clones
showed significantly lower levels of p53 protein than did the wild-
type N2A cells (Figure 6A). These findings suggest that p53 may
not be required for EGR-1-induced apoptosis in these cells.
It has been shown that stability of the p53 protein is reduced
significantly by the mdm2 protein; therefore we studied whether
the decreased levels in p53 protein observed in the clones NG9 and
NG10 could be due to the regulation of the mdm2 gene by EGR-1.
To this end we performed Western-blot analysis, using a specific
anti-mdm2 antibody, and transient co-transfections of parental
N2A cells with a reporter construct that contains 400 bp of the
mdm2 promoter region (P2) and an EGR-1 expression plasmid. As
shown in Figure 6(A), the content of mdm2 protein is undetectable
in parental N2A cells and its levels are clearly induced in the NG9
and NG10 clones. The activity of the reporter construct was also
significantly increased (2.2-fold) by co-transfection with EGR-1
(Figure 6B). We next tested mdm2 promoter activity in parental
N2A cells and cells overexpressing EGR-1 (Figure 6C). In these
experiments, we also noted a strong increase in luciferase reporter
activity in cells stably expressing the EGR-1 protein: 3.2- and 6.3-
fold (NG9 and NG10 respectively) increases over basal values (i.e.
N2A cells), which is in agreement with the higher levels of mdm2
protein observed in these clones. These findings suggested that an
induction of mdm2 could be responsible for the observed decrease
in p53 and also allow us to add the mdm2 gene to the growing list
of genes regulated by EGR-1.
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Figure 7 Effect of p53 suppression on EGR-1-induced apoptosis
Parental N2A cells and clones NG9 and NG10 were grown in 60-mm plates and transfected with
2 µg of pSUPER/p53 or pSUPER vectors, as indicated in the Materials and methods section,
and analysed 50 h later. (A) The protein levels of p53 in parental N2A cells and clones NG9 and
NG10 were determined by Western-blot analysis. Equal protein amounts (20 µg) of each sample
were subjected to SDS/PAGE, transferred to nitrocellulose and blots were incubated with specific
anti-p53 as described in the Materials and methods section. (B) Quantitative determination of
apoptotic cells determined by PI staining and flow cytometry. Values represent the means +− S.D.
from at least three different experiments; **P  0.01, ***P  0.001.
To further confirm that the EGR-1-induced apoptosis in N2A
cells does not require the p53 gene, we designed a construct to
knockdown p53 protein. As shown by Brummelkamp et al. [32],
appropriate constructions with the pSUPER vector are able to dir-
ect the synthesis of small-interfering-RNA- (‘siRNA’)-like trans-
cripts causing efficient and specific down-regulation of gene
expression resulting in functional inactivation of the target gene.
In Figure 7(A), we show that clones NG9 and NG10, and parental
N2A cells transfected with the pSUPER/p53 construct, presented
diminished levels of p53 protein compared with the same cells
transfected with pSUPER empty vector. This marked decrease of
p53 protein had no effect on apoptosis induced by overexpression
of EGR-1 (Figure 7B), suggesting again that the EGR-1-induced
apoptosis of N2A cells is independent of p53.
Although p53 plays an essential proapoptotic role, this function
is shared with other family members such as the p73 protein.
Therefore, to investigate whether the p73 protein could mediate
the enhanced apoptosis observed in the clones overexpressing the
EGR-1 protein, we first performed Western-blot analysis with a
specific anti-p73 antibody. As shown in Figure 8(A) there is
a significant increase in p73 in clones NG9 and NG10 as com-
pared with parental N2A cells. Several reports have shown that
p73 binds to p53-binding sites and, consequently, activates pro-
moters containing these sequences. We next performed transient
transfections experiments using the reporter construct pG13-luc,
which contains multiple p53-binding sites linked to a basal pro-
moter [35]. As can be seen in Figure 8(B), when the p53 reporter
construct pG13-luc was transfected into N2A cells and clones
Figure 8 Effect of EGR-1 on p73 expression
(A) The protein levels of p73 in parental N2A cells and clones NG9 and NG10 were determined
by Western-blot analysis. Equal protein amounts (20 µg) of each sample were subjected to
SDS/PAGE, transferred to nitrocellulose and blots were incubated with specific anti-p73 as
described in the Materials and methods section. (B) N2A cells and clones NG9 and NG10 were
transfected with 0.5 µg of pG13-luc vector, and 24 h after transfection, luciferase activity of cell
lysates was determined. The histogram shows the means +− S.D. from at least three separate
experiments in triplicate; ***P  0.001.
NG9 and NG10, a clear induction of luciferase activity was ob-
served in the two clones. These data suggest a possible involve-
ment of p73 protein in the EGR-1-induced apoptosis in N2A
cells.
DISCUSSION
A hallmark of the nervous system is the extensive histogenetic
cell death that takes place relatively late in maturation and results
in the loss of 20–70% of all neurons [36]. This cell death occurs
by apoptosis, a genetically controlled response for cells to commit
suicide, a process in which many genes seem to be involved. In
this study we have shown that the EGR-1 gene is involved in the
apoptosis induced by serum withdrawal in neuroblastoma cells.
Furthermore, the enforced expression of EGR-1 in these cells is
able to induce apoptosis even in the presence of serum, suggesting
that this gene could participate in the decision to commit to
the death pathway directly, rather than having an impact on the
manifestation of the death process once the pathway has been
activated. The apoptotic effect of EGR-1 could be mediated by the
p73 protein and seems to be independent of p53 since an increase
in p73 protein, paralleled by a decrease in p53, was observed in
cells overexpressing EGR-1.
Since the discovery of the EGR-1 gene as an ‘early growth
response gene’, research was directed towards a function of this
gene in growth and proliferation. However, EGR-1 expression
has also been linked to cell death [37]. In the nervous system,
an enhanced expression of EGR-1 has been linked with neuronal
apoptosis of both primary cultures of cerebellar granule cells and
neuroblastoma cell lines [38–40]. Cerebellar granule cell death
induced by withdrawal of depolarizing concentrations of K+
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is accompanied by an induction of endogenous EGR-1 levels.
However, although a dominant-negative inhibitor construct blocks
granule-cell apoptosis, increased expression of EGR-1 was not
sufficient to activate the apoptotic process [41]. Also, it has
been reported that an impairment of EGR-1 biosynthesis has no
effect upon apoptosis induced by anti-depressants in HT22 im-
mortalized hippocampal neurons [40]. Our results clearly show
that, in N2A cells, EGR-1 is required for apoptosis induced by
serum deprivation. Furthermore, overexpression of the EGR-1
protein can efficiently promote the apoptotic programme of neuro-
blastoma cells.
Previous reports have shown that EGR-1 plays a role in thapsi-
gargin or ionizing radiation-inducible apoptosis in human mela-
noma cells A375-C6 and prostate cells [34,42]. In human
melanoma cells, wild-type p53 was required for EGR-1-
dependent apoptosis caused by thapsigargin. Nair et al. [34] ob-
served two EGR-1-binding sites in the p53 promoter and one
of the sites tested was found to bind EGR-1; consistent with
this finding, EGR-1 caused transcriptional up-regulation of the
p53 gene promoter and increased p53 transcript and protein
levels. However, the possibility that EGR-1 may utilize a p53-
independent pathway, in the case of ionizing radiation-inducible
apoptosis, has been suggested by the finding that a dominant-
negative mutant of EGR-1 abrogated radiation-inducible apo-
ptosis despite induction of wild-type p53 [43]. This hypothesis
was confirmed by studies in prostate cancer PC-3 cells that lack
p53 protein [44]. In our system, overexpression of EGR-1 results
in a decrease of p53 protein levels, which is in contrast with
the previous observation by Na¨ir et al. [34] in human melanoma
cells, commented on above. This could be the consequence of
a different cell background since it has been shown that the
activity of EGR-1 is dependent on multiple factors [45]. The effect
of EGR-1 on p53 protein levels, shown in this paper, suggests
that this protein does not mediate EGR-1-induced apoptosis of
N2A cells and, therefore, that p53 is not required for all EGR-1
signalling pathways leading to apoptosis. This conclusion is
further supported by the results showing that, in NG9 and NG10
clones transfected with the pSUPER/p53 construct and presenting
even lower levels of p53 protein, the percentage of apoptotic cells
doesn’t change.
Two genes, p63 and p73 [46], have been found to encode
several proteins whose structure and functions are similar, but
not identical, to those of p53. It has been shown that p73 is
able to induce apoptosis when overexpressed [47]. p73 apoptotic
functions are also recruited in response to DNA damage, through
a p53-independent pathway that requires the activation of the
nuclear tyrosine kinase c-Abl [48,49]. Our data suggest that
the apoptosis induced by EGR-1 in N2A cells could be mediated
by an increase in p73 protein levels and the subsequent
enhancement in its transactivation activity. The effect of EGR-
1 protein on p73 gene expression could be a direct one since
it has been described in the presence of EGR-1 binding sites
in the promoter of this gene [50]. Therefore cell-type-specific
mechanisms may determine the mechanism of action of EGR-1
upon programmed cell death. Differential regulation by
EGR-1 has been described for other genes, like the platelet-
derived growth factor A-chain that is dependent on cell type
[51,52]. It is interesting to point out that a suppression in p53
protein levels [53] and an overexpression of p73 [54] have
also been associated with an increase in neurite outgrowth and
expression of neuronal differentiation markers. In agreement with
this, we have previously found that the ectopic expression of EGR-
1 in N2A cells induces neuronal differentiation [23].
The p53 protein is significantly destabilized by the over-
expression of mdm2 [55,56], leading to the postulation that mdm2
may play a role in maintaining low levels of p53 in normal
cells as well as in removing p53 during recovery from stress-
induced arrest through a feedback-regulatory loop. The mdm2
protein is able to form a protein–protein interaction with p53,
which inactivates the transactivation function of p53 [57,58] and
overexpression of mdm2 leads to a significant destabilization of
the p53 protein inhibiting the ability of p53 to evoke cell-cycle
arrest or induce apoptosis [55,56,59]. Our results clearly show
an up-regulation of the mdm2 promoter and protein content by
the EGR-1 protein, which probably plays an important role in the
reduction of p53 protein levels observed in clones overexpressing
the EGR-1 protein. This observation is particularly important
since it implicates the EGR-1 gene as a regulator of a gene
involved in crucial cellular processes such as apoptosis and cell-
cycle regulation.
The studies described herein, together with previous reports
regarding the regulation of EGR-1 gene expression and its
possible role in neuronal tissues [25,60,61] suggest that EGR-1
levels may play a significant role in neuronal cell survival during
development of the central nervous system. Our results also
suggest an implication of the p73 protein in the effect of EGR-1
on N2A cell death through a mechanism independent of p53.
Analysis of the downstream signal transduction of the EGR-1-
induced apoptosis might be useful for understanding the general
mechanism of neuronal cell death.
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